United Health Products (UEEC) EBIAT (2016 - 2025)
United Health Products (UEEC) has disclosed EBIAT for 15 consecutive years, with -$285594.0 as the latest value for Q3 2025.
- On a quarterly basis, EBIAT rose 5.95% to -$285594.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.9 million, a 77.55% decrease, with the full-year FY2024 number at -$2.0 million, up 23.69% from a year prior.
- EBIAT was -$285594.0 for Q3 2025 at United Health Products, up from -$315187.0 in the prior quarter.
- In the past five years, EBIAT ranged from a high of $820567.0 in Q3 2022 to a low of -$27.0 million in Q1 2021.
- A 5-year average of -$2.1 million and a median of -$664767.0 in 2022 define the central range for EBIAT.
- Peak YoY movement for EBIAT: crashed 4221.86% in 2021, then soared 213.27% in 2022.
- United Health Products' EBIAT stood at -$1.5 million in 2021, then skyrocketed by 54.87% to -$664767.0 in 2022, then rose by 29.01% to -$471918.0 in 2023, then tumbled by 72.51% to -$814112.0 in 2024, then soared by 64.92% to -$285594.0 in 2025.
- Per Business Quant, the three most recent readings for UEEC's EBIAT are -$285594.0 (Q3 2025), -$315187.0 (Q2 2025), and -$1.5 million (Q1 2025).